Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,6013,620 of 20,252 grants

Active OTHER RESEARCH-RELATED
Mechanisms of gene expression regulation in pancreatic cancer
NATIONAL CANCER INSTITUTE Whitehead Institute for Biomedical Res United States 2023 – 2028

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second deadliest cancer within the next 10-years. Investigations into novel mechanisms of PDAC tr...

$1.04M
USD
Active NON-SBIR/STTR RPGS
Exosomal biomarkers for the early detection of hepatocellular carcinoma
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

PROJECT SUMMARY: Liver cancer is estimated to afflict 42,230 individuals and result in approximately 30,230 deaths in the US in 2021. The incidence rates for liver cancer have more...

$7.45M
USD
Completed SBIR-STTR RPGS
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)
NATIONAL CANCER INSTITUTE Nanovalent Pharmaceuticals, Inc United States 2023 – 2024

Project Summary The goal of this Fast Track STTR project is to determine proof-of-principle and efficacy of a novel blood brain barrier (BBB) penetrating therapeutic nanoparticle f...

$4M
USD
Active NON-SBIR/STTR RPGS
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
NATIONAL CANCER INSTITUTE Rand Corporation United States 2023 – 2028

PROJECT SUMMARY Cervical cancer (CC) is the leading cause of cancer-related deaths among women in Uganda, which has one of the world’s highest incidence rates. Evidence-based visua...

$5.73M
USD
Active NON-SBIR/STTR RPGS
Exosomal biomarkers for the early detection of hepatocellular carcinoma
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2023 – 2028

PROJECT SUMMARY: Liver cancer is estimated to afflict 42,230 individuals and result in approximately 30,230 deaths in the US in 2021. The incidence rates for liver cancer have more...

$6.93M
USD
Active SBIR-STTR RPGS
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)
NATIONAL CANCER INSTITUTE Nanovalent Pharmaceuticals, Inc United States 2023 – 2026

Project Summary The goal of this Fast Track STTR project is to determine proof-of-principle and efficacy of a novel blood brain barrier (BBB) penetrating therapeutic nanoparticle f...

$10M
USD
Active NON-SBIR/STTR RPGS
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
NATIONAL CANCER INSTITUTE Rand Corporation United States 2023 – 2028

PROJECT SUMMARY Cervical cancer (CC) is the leading cause of cancer-related deaths among women in Uganda, which has one of the world’s highest incidence rates. Evidence-based visua...

$6.38M
USD
Active NON-SBIR/STTR RPGS
Novel DNA cross-linking agents and combination strategies for tumor-specific activation
NATIONAL CANCER INSTITUTE University of Wisconsin Milwaukee United States 2023 – 2026

Project summary/abstract Cancer cells are in a state of increased basal oxidative stress due to their aberrant growth. As a result, cancer cells have elevated levels of reactive ox...

$4.62M
USD
Active OTHER RESEARCH-RELATED
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Autologous CD19-directed chimeric antigen receptor T-cells (CAR-T) have resulted in extraordinary response rates in relapsing and refractory large B-cell l...

$2.78M
USD
Active NON-SBIR/STTR RPGS
Amyloid-bodies and the Evolution of Malignancies
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2023 – 2028

Diversity Supplement Project Summary The ability of cancer cells to adapt to a wide variety of stress conditions plays a critical role in various physiological facets of tumorigene...

$767.5K
USD
Completed SBIR-STTR RPGS
Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment
NATIONAL CANCER INSTITUTE Lamassu Bio Inc United States 2023 – 2025

Project summary/abstract This proposal advances the development of a novel therapeutic for p53 wild type sarcomas. Our team has identified a novel MDM2 inhibitor, SA53, with best-i...

$7.23M
USD
Active NON-SBIR/STTR RPGS
Multi-level school-based intervention to improve HPV vaccine uptake and completion in South Africa
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2026

PROJECT SUMMARY Human Papillomavirus (HPV) is the most common sexually transmitted infection globally, and is causally linked to cervical, anogenital, and oropharyngeal cancers. HP...

$2.41M
USD
Active NON-SBIR/STTR RPGS
Amyloid-bodies and the Evolution of Malignancies
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2023 – 2028

Amyloid-bodies and the Evolution of Malignancies Project Summary The ability of cancer cells to adapt to a wide variety of stress conditions plays a critical role in various physio...

$3.79M
USD
Completed SBIR/STTR CONTRACTS
Rapid Point of Care Test to Screen Human Papillomavirus in Low-Resource Settings
NATIONAL CANCER INSTITUTE Zymeron Corporation United States 2023 – 2024

Cervical cancer caused by human papillomavirus (HPV) is the fourth most common cancer among women worldwide, but it is preventable by screening asymptomatic women before HPV infect...

$137.2K
USD
Completed SBIR-STTR RPGS
Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment
NATIONAL CANCER INSTITUTE Lamassu Bio Inc United States 2023 – 2025

Project summary/abstract This proposal advances the development of a novel therapeutic for p53 wild type sarcomas. Our team has identified a novel MDM2 inhibitor, SA53, with best-i...

$13.04M
USD
Active OTHER RESEARCH-RELATED
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Autologous CD19-directed chimeric antigen receptor T-cells (CAR-T) have resulted in extraordinary response rates in relapsing and refractory large B-cell l...

$2.78M
USD
Active NON-SBIR/STTR RPGS
Multi-level school-based intervention to improve HPV vaccine uptake and completion in South Africa
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2026

PROJECT SUMMARY Human Papillomavirus (HPV) is the most common sexually transmitted infection globally, and is causally linked to cervical, anogenital, and oropharyngeal cancers. HP...

$3.4M
USD
Active NON-SBIR/STTR RPGS
Amyloid-bodies and the Evolution of Malignancies
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2023 – 2028

Amyloid-bodies and the Evolution of Malignancies Project Summary The ability of cancer cells to adapt to a wide variety of stress conditions plays a critical role in various physio...

$3.88M
USD
Completed NON-SBIR/STTR RPGS
Development of a clinically relevant mouse model of lung cancer cachexia to study pathoetiology and therapeutic strategies
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2023 – 2025

PROJECT SUMMARY Cancer cachexia (CC) is characterized by unintentional weight loss secondary to adipose and skeletal muscle tissue wasting. It results from a complex interaction be...

$2.19M
USD
Active NON-SBIR/STTR RPGS
Reprogramming Exosomes for Novel Immunotherapy of Triple Negative Breast Cancer
NATIONAL CANCER INSTITUTE University of Southern California United States 2023 – 2028

Abstract Triple negative breast cancer (TNBC) accounts for approximately 15-20% of breast cancers and is the most aggressive subtype of breast cancer. Given little efficacy for exi...

$5.12M
USD